TCI LVAD Trials Hope To Show Device As "Destination Technique"
This article was originally published in The Gray Sheet
Executive Summary
Long-term use of electric left ventricular assist devices (LVADs) as a "destination technique" rather than a bridge to transplantation is being examined by Thermo Cardiosystems, Inc.' s REMATCH trial, Eric Rose, MD, Columbia Presbyterian Hospital, told attendees of the American Heart Association's 71st Scientific Sessions Nov. 11 in Dallas.